1. Home
  2. DTSS vs ADXN Comparison

DTSS vs ADXN Comparison

Compare DTSS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.92

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$7.12

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
ADXN
Founded
2014
2002
Country
China
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
10.3M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
DTSS
ADXN
Price
$0.92
$7.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.7K
3.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$71,616,820.00
N/A
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
198.70
N/A
52 Week Low
$0.64
$6.51
52 Week High
$2.70
$12.05

Technical Indicators

Market Signals
Indicator
DTSS
ADXN
Relative Strength Index (RSI) 45.61 42.76
Support Level $0.81 $6.82
Resistance Level $0.98 $8.74
Average True Range (ATR) 0.09 0.29
MACD -0.00 -0.04
Stochastic Oscillator 45.72 12.61

Price Performance

Historical Comparison
DTSS
ADXN

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: